These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38586842)

  • 1. Impact of age on hospital outcomes after catheter ablation for ventricular tachycardia.
    Tan MC; Yeo YH; Ang QX; Kiwan C; Fatunde O; Lee JZ; Tolat A; Sorajja D
    J Arrhythm; 2024 Apr; 40(2):317-324. PubMed ID: 38586842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes, Costs, and 30-Day Readmissions After Catheter Ablation of Myocardial Infarct-Associated Ventricular Tachycardia in the Real World: Nationwide Readmissions Database 2010 to 2015.
    Cheung JW; Yeo I; Ip JE; Thomas G; Liu CF; Markowitz SM; Lerman BB; Kim LK
    Circ Arrhythm Electrophysiol; 2018 Nov; 11(11):e006754. PubMed ID: 30376735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Paroxysmal Versus Persistent Atrial Fibrillation with In-hospital Outcomes and 30-day Readmission After Inpatient Atrial Fibrillation Ablation.
    Tan MC; Yeo YH; Ang QX; Tan BE; Tan JL; Rattanawong P; Correia J; Tolat A
    J Innov Card Rhythm Manag; 2024 Jun; 15(6):5894-5901. PubMed ID: 38948660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty-day readmission after catheter ablation for ventricular tachycardia: associated factors and outcomes.
    Tan MC; Ang QX; Yeo YH; Deshmukh A; Scott LR; Hussein AA; Sroubek J; Santangeli P; Wazni OM; Lee JZ
    J Interv Card Electrophysiol; 2024 Apr; 67(3):513-521. PubMed ID: 37530968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of obesity on catheter ablation of ventricular tachycardia: In-hospital and 30-day outcomes.
    Tan MC; Yeo YH; Ang QX; Tan BE; Rattanawong P; Tan JL; Lee JZ
    J Arrhythm; 2023 Aug; 39(4):672-675. PubMed ID: 37560290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world characteristics and readmissions among patients undergoing ablation for ventricular tachycardia: a retrospective database analysis of commercially insured patients in the USA.
    Mehta V; Boo LM; Ghaly N; Kalsekar I; Zhang S; Yadalam S; Khanna R; Rahman M
    Open Heart; 2020 Sep; 7(2):. PubMed ID: 32998979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world outcomes of ventricular tachycardia catheter ablation with versus without intracardiac echocardiography.
    Field ME; Gold MR; Reynolds MR; Goldstein L; Lee SHY; Kalsekar I; Coplan P; Wong C; Khanna R; Winterfield JR
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):417-422. PubMed ID: 31868258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation compared to medical therapy for ventricular tachycardia in sarcoidosis: nationwide outcomes and hospital readmissions.
    Gurin MI; Xia Y; Tarabanis C; Goldberg RI; Knotts RJ; Donnino R; Reyentovich A; Bernstein S; Jankelson L; Kushnir A; Holmes D; Spinelli M; Park DS; Barbhaiya CR; Chinitz LA; Aizer A
    Am Heart J Plus; 2024 Aug; 44():100421. PubMed ID: 39070127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Ventricular Tachycardia Catheter Ablation in Patients Who Underwent Cardiac Defibrillator Implantation Nationwide Readmission Database Analysis.
    Moustafa A; Elzanaty A; Karim S; Eltahawy E; Kahaly O; Elbatanony L; Khalil M; Maraey A; Chacko P
    Am J Cardiol; 2023 Jul; 198():108-112. PubMed ID: 37188567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes associated with inpatient ventricular tachycardia catheter ablation.
    Sharma P; Tripathi B; Naraparaju V; Patel M; Bhagat A; Yerasi C; Kumar V; Aujla P; Singh G; Lahewala S; Arora S; Deshmukh A; Tolat A
    Pacing Clin Electrophysiol; 2020 May; 43(5):444-455. PubMed ID: 32196697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort.
    Yousuf OK; Zusterzeel R; Sanders W; Caños D; Dekmezian C; Silverman H; Calkins H; Berger R; Tandri H; Nazarian S; Strauss DG
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1189-1199. PubMed ID: 30236393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of intracardiac echocardiography in ventricular tachycardia ablation: a nationwide observational study.
    Kitamura T; Nakajima M; Kawamura I; Kaszynski RH; Ohbe H; Sasabuchi Y; Matsui H; Fushimi K; Fukamizu S; Yasunaga H
    Heart Vessels; 2021 Jul; 36(7):1009-1015. PubMed ID: 33475763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of catheter ablation of ventricular tachycardia: a single-center experience.
    Peichl P; Wichterle D; Pavlu L; Cihak R; Aldhoon B; Kautzner J
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):684-90. PubMed ID: 24958396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Catheter Ablation for Ventricular Tachycardia in Elderly Patients With Structural Heart Disease.
    Liang JJ; Khurshid S; Schaller RD; Santangeli P; Marchlinski FE; Frankel DS
    JACC Clin Electrophysiol; 2015; 1(1-2):52-58. PubMed ID: 29759339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term success of a multi-electrode substrate mapping and ablation strategy versus a classic single tip mapping and ablation strategy for ventricular tachycardia ablation in patients with ischemic cardiomyopathy.
    Balt JC; Abeln BGS; Mahmoodi BK; van Dijk VF; Wijffels MCEF; Boersma LVA
    Pacing Clin Electrophysiol; 2023 Jul; 46(7):574-582. PubMed ID: 37254956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: Insights from the national readmission database.
    Khalil M; Maraey A; Aglan A; Akintoye E; Salem M; Elzanaty AM; Younes A; Saeyeldin A; Barbhaiya CR; Shokr M
    J Interv Card Electrophysiol; 2023 Mar; 66(2):323-331. PubMed ID: 35314904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of catheter ablation for ventricular tachycardia in patients with sarcoidosis: Insights from the National Inpatient Sample database (2002-2018).
    Tan JL; Jin C; Lee JZ; Gaughan J; Iwai S; Russo AM
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2585-2598. PubMed ID: 36335632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database.
    Aryana A; d'Avila A; Cool CL; Miller MA; Garcia FC; Supple GE; Dukkipati SR; Lakkireddy D; Bunch TJ; Bowers MR; O'Neill PG; Reddy VY; Marchlinski FE
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1295-1302. PubMed ID: 28800178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of catheter ablation for ventricular tachycardia in elderly patients with structural heart disease: a systematic review and meta-analysis.
    Blandino A; Bianchi F; Frankel DS; Liang JJ; Mazzanti A; D'Ascenzo F; Masi AS; Grossi S; Musumeci G
    J Interv Card Electrophysiol; 2023 Jan; 66(1):179-192. PubMed ID: 34436722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.
    Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E
    Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.